Phase III Randomized Study of Poloxamer 188 for Vaso-Occlusive Crisis of Sickle Cell Disease

This study has been terminated.

( lack of funding )

Study NCT00004408 Information provided by Adventrx Pharmaceuticals

First Received: October 18, 1999 Last Updated: February 8, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	November 1999
Primary Completion Date:	November 1999 (Final data collection date for primary outcome measure)